Viewing Study NCT02103335


Ignite Creation Date: 2025-12-24 @ 10:08 PM
Ignite Modification Date: 2025-12-25 @ 7:44 PM
Study NCT ID: NCT02103335
Status: COMPLETED
Last Update Posted: 2017-11-22
First Post: 2014-03-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma
Sponsor: Celgene
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-06-05
Start Date Type: ACTUAL
Primary Completion Date: 2016-10-03
Primary Completion Date Type: ACTUAL
Completion Date: 2016-11-30
Completion Date Type: ACTUAL
First Submit Date: 2014-03-27
First Submit QC Date: None
Study First Post Date: 2014-04-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-11-20
Last Update Post Date: 2017-11-22
Last Update Post Date Type: ACTUAL